Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis
Eur Neuropsychopharmacol. 2025 Nov 7;101:41-55. doi: 10.1016/j.euroneuro.2025.09.011. Online ahead of print. ABSTRACT Serotonergic psychedelics and 3,4-methylendioxtmethamphetamine (MDMA) are promising treatments for mental disorders with a …